Share-based Payment Arrangement, Expense in USD of HTG MOLECULAR DIAGNOSTICS, INC from 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly and annual Share-based Payment Arrangement, Expense history and change rate from 2014 to Q1 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2023 was $137,108, a 48.8% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2023 was $643,463, a 47.9% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Share-based Payment Arrangement, Expense for 2022 was $774,160, a 41.2% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Share-based Payment Arrangement, Expense for 2021 was $1,317,355, a 16.9% decline from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Share-based Payment Arrangement, Expense for 2020 was $1,584,785, a 37% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $643,463 $137,108 -$130,697 -49% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $774,160 $100,274 -$174,763 -64% 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
Q3 2022 $948,923 $174,747 -$164,146 -48% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,113,069 $231,334 -$121,152 -34% 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,234,221 $267,805 -$83,134 -24% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $1,317,355 $275,037 -$130,034 -32% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,447,389 $338,893 -$53,270 -14% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $1,500,659 $352,486 -$14,394 -3.9% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $1,515,053 $350,939 -$69,732 -17% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $1,584,785 $405,071 +$93,637 +30% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $1,491,148 $392,163 +$75,608 +24% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $1,415,540 $366,880 +$79,548 +28% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $1,335,992 $420,671 +$179,425 +74% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $1,156,567 $311,434 +$66,732 +27% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $1,089,835 $316,555 +$58,580 +23% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $1,031,255 $287,332 +$45,412 +19% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2
Q1 2019 $985,843 $241,246 -$902,212 -79% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $1,888,055 $244,702 -$19,397 -7.3% 01 Oct 2018 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 $1,907,452 $257,975 -$99,430 -28% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $2,006,882 $241,920 -$176,017 -42% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $2,182,899 $1,143,458 +$746,812 +188% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $1,436,087 $264,099 -$185,975 -41% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q3 2017 $1,622,062 $357,405 +$127,487 +55% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $1,494,575 $417,937 +$265,849 +175% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $1,228,726 $396,646 +$226,598 +133% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $1,002,128 $450,074 +$268,435 +148% 01 Oct 2016 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q3 2016 $733,693 $229,918 +$152,679 +198% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $581,014 $152,088 +$82,088 +117% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $498,926 $170,048 +$93,500 +122% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $405,426 $181,639 01 Oct 2015 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q3 2015 $77,239 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $70,000 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $76,548 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

HTG MOLECULAR DIAGNOSTICS, INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $774,160 -$543,195 -41% 01 Jan 2022 31 Dec 2022 10-K 30 Mar 2023 2022 FY
2021 $1,317,355 -$267,430 -17% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $1,584,785 +$428,218 +37% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $1,156,567 -$731,488 -39% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $1,888,055 +$451,968 +31% 01 Jan 2018 31 Dec 2018 10-K 25 Mar 2020 2019 FY
2017 $1,436,087 +$433,959 +43% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $1,002,128 +$596,702 +147% 01 Jan 2016 31 Dec 2016 10-K 23 Mar 2018 2017 FY
2015 $405,426 +$220,460 +119% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2017 2016 FY
2014 $184,966 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.